Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,553 across all filing types
Latest filing 2017-01-18 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
FY2017 Profit Upgrade 2 pages 71.1KB
Regulatory Filings
2017-01-18 English
Change to Company Details 6 pages 74.2KB
Regulatory Filings
2017-01-09 English
AFSTYLA (rFVIII-Single Chain) European Commission Approval 2 pages 56.4KB
Regulatory Filings
2017-01-08 English
Appendix 3B 8 pages 141.8KB
Regulatory Filings
2017-01-02 English
Daily share buy-back notice - Appendix 3E 2 pages 10.6KB
Regulatory Filings
2016-12-20 English
Daily share buy-back notice - Appendix 3E 2 pages 10.6KB
Regulatory Filings
2016-12-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.